Nanostructured Molecular Materials for Biomedicine (NANOMOL-BIO)
Molecular and polymeric nanomaterials for therapy, diagnosis, drug delivery, bioimaging, regenerative medicine and cancer immunotherapy.
Nanostructured molecular materials for biomedical innovation
The NANOMOL-BIO group is devoted to the synthesis, physico-chemical characterization and development of molecular and polymeric nanomaterials for biomedical applications.
The group advances materials from fundamental molecular design towards pre-clinical regulatory phases, connecting nanostructured materials science with therapy, diagnosis, regenerative medicine and bioimaging.
Its research contributes to the ICMAB materials for health ecosystem through nanovesicles, organic nanoparticles, hydrogels, dendrimers and hybrid nanosystems designed for biomedical performance.
Research challenges
NANOMOL-BIO designs molecular and polymeric nanomaterials to address biomedical challenges in therapy, diagnosis, infection prevention, imaging and regenerative medicine.
Therapy delivery
Diagnosis and imaging
Infection prevention
Regenerative medicine
Main research areas
The group structures its activity around molecular materials for therapy and molecular materials for diagnosis.
Materials, methods and translational approach
NANOMOL-BIO combines molecular synthesis, polymeric nanomaterials, physico-chemical characterization and biomedical validation to develop functional nanosystems with therapeutic and diagnostic potential.
The group’s work bridges materials chemistry, nanomedicine, biointerfaces and pre-clinical development, reinforcing the role of advanced materials in future healthcare technologies.
Molecular synthesis
Physico-chemical characterization
Nanomedicine development
Pre-clinical orientation
People
Scientific, technical and research staff associated with the NANOMOL-BIO research group.
Permanent Scientific Researchers
Postdoctoral & Project Researchers
Technicians and Administrative Managers
Connected to the ICMAB materials for health ecosystem
NANOMOL-BIO contributes molecular nanomaterials expertise to ICMAB’s advanced materials research ecosystem, especially in health, nanomedicine and biomedical technologies.
Contact and group website
For detailed information about NANOMOL-BIO research activity, current projects, publications and opportunities, visit the external group website or contact the group through the corresponding ICMAB channels.
Nanostructured Molecular Materials for Biomedicine
Molecular and polymeric nanomaterials for therapy, diagnosis, drug delivery, bioimaging, regenerative medicine and cancer immunotherapy.

